Iovance Biotherapeutics, Inc. (IOVA) News Headlines

▮ More

Date

Headline

12/5/2022 7:51:19 AM Pre-market Movers: IOVA, DADA, SHPH, BILI, BVS…

11/18/2022 10:02:49 AM Iovance Declines Following FDA Feedback On Its Melanoma Drug Lifileucel

8/25/2022 7:58:33 AM Iovance Biotherapeutics Initiates BLA Submission For Lifileucel In Advanced Melanoma

5/27/2022 7:44:40 AM Pre-market Movers: IOVA, MRTX, BIG, GPS, PMVP…

9/23/2021 7:47:29 AM Iovance Biotherapeutics Begins Clinical Supply Of TIL Cell Therapy Manufactured At Iovance Cell Therapy Center

6/29/2021 10:14:24 AM Iovance Biotherapeutics Down 4%; Releases Clinical Data For Its TIL Therapy LN-145

6/29/2021 6:34:47 AM Iovance Biotherapeutics Announces Clinical Data For LN-145 In Non-Small Cell Lung Cancer

5/20/2021 11:08:52 AM Stock Alert: Iovance Biotherapeutics Up 16%

5/18/2021 5:18:22 PM Iovance Biotherapeutics Shares Slip 10% On FDA's Feed Back On Lifileucel

4/10/2018 8:45:12 AM B. Riley FBR Upgrades Iovance Biotherapeutics, Inc. (IOVA) To Buy From Neutral With $22 Price Target

Older Articles